Chief Laboratory Director
Lab for Molecular Medicine, Mass General Brigham Personalized Medicine
Dr. Matthew Lebo is the Chief Laboratory Director of the Laboratory for Molecular Medicine (LMM), a CLIA-certified molecular diagnostics laboratory, and the Director of Bioinformatics within Mass General Brigham Personalized Medicine. He is an Associate Professor of Pathology at Harvard Medical School and an Associate Member of the Broad Institute of MIT and Harvard. Dr. Lebo’s research focuses on driving forward the routine use of genomics and computational biology in translational and clinical applications, specifically in genomic-based applications and high-throughput screening of unaffected individuals. He also participates in standards and guidelines development, including co-chairing the ClinGen Low-Penetrance/Risk Allele Work Group, and is actively involved in large research consortia, including eMERGE and AnVIL.